SOUTH KOREA · OPENDART
HUONS CO., LTD.
휴온스 · 243070 · KOSDAQ · Healthcare · Drug Manufacturers—Specialty & Generic
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
No exchange purchase by an insider is on record yet.
Other changes in holdings · 6
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-01-01 | Park Hye-mi | Director | New appointment(+) | 2,102 | DART ↗ |
| 2026-01-01 | Oh Seok-gyun | Director | New appointment(+) | 220 | DART ↗ |
| 2025-12-19 | Yoon In Sang | Vice president | Receipt of donation(+) | 360,750 | DART ↗ |
| 2025-12-19 | Yoon Sung Tae | Chairman | Donation(-) | 360,750 | DART ↗ |
| 2025-04-18 | Yoon In Sang | Managing director | Receipt of donation(+) | 42,000 | DART ↗ |
| 2025-04-18 | Yoon Sung Tae | Chairman | Donation(-) | 117,000 | DART ↗ |